Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jul 6;12(7):7519-40.
doi: 10.3390/ijerph120707519.

Manganese-Induced Parkinsonism and Parkinson's Disease: Shared and Distinguishable Features

Gunnar F Kwakye  1 , Monica M B Paoliello  2 , Somshuvra Mukhopadhyay  3 , Aaron B Bowman  4 , Michael Aschner  5
Affiliations
Review

Manganese-Induced Parkinsonism and Parkinson's Disease: Shared and Distinguishable Features

Gunnar F Kwakye et al. Int J Environ Res Public Health. .

Abstract

Manganese (Mn) is an essential trace element necessary for physiological processes that support development, growth and neuronal function. Secondary to elevated exposure or decreased excretion, Mn accumulates in the basal ganglia region of the brain and may cause a parkinsonian-like syndrome, referred to as manganism. The present review discusses the advances made in understanding the essentiality and neurotoxicity of Mn. We review occupational Mn-induced parkinsonism and the dynamic modes of Mn transport in biological systems, as well as the detection and pharmacokinetic modeling of Mn trafficking. In addition, we review some of the shared similarities, pathologic and clinical distinctions between Mn-induced parkinsonism and Parkinson's disease. Where possible, we review the influence of Mn toxicity on dopamine, gamma aminobutyric acid (GABA), and glutamate neurotransmitter levels and function. We conclude with a survey of the preventive and treatment strategies for manganism and idiopathic Parkinson's disease (PD).

Keywords: Parkinson’s disease (PD); manganese neurotoxicity; manganese-induced parkinsonism; manganism; neurodegenerative diseases.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Erikson K.M., Syversen T., Aschner J.L., Aschner M. Interactions between excessive manganese exposures and dietary iron-deficiency in neurodegeneration. Environ. Toxicol. Pharmacol. 2005;19:415–421. doi: 10.1016/j.etap.2004.12.053. - DOI - PubMed
    1. Takeda A. Manganese action in brain function. Brain Res. Rev. 2003;41:79–87. doi: 10.1016/S0165-0173(02)00234-5. - DOI - PubMed
    1. Aschner M., Erikson K.M., Dorman D.C. Manganese dosimetry: Species differences and implications for neurotoxicity. CRC Crit. Rev. Toxicol. 2005;35:1–32. doi: 10.1080/10408440590905920. - DOI - PubMed
    1. Pennington J.A., Young B.E., Wilson D.B., Johnson R.D., Vanderveen J.E. Mineral content of foods and total diets: The selected minerals in foods survey, 1982 to 1984. J. Am. Diet. Assoc. 1986;86:876–891. - PubMed
    1. Benedetto A., Au C., Aschner M. Manganese-induced dopaminergic neurodegeneration: Insights into mechanisms and genetics shared with Parkinson’s disease. Chem. Rev. 2009;109:4862–4884. doi: 10.1021/cr800536y. - DOI - PubMed

Publication types